Business Description
ChromoGenics AB
ISIN : SE0020847481
Compare
Compare
Traded in other countries / regions
CHRO.Sweden384.Germany IPO Date
2017-06-27Description
ChromoGenics AB develops and produces dynamic glass with controllable optical properties in Sweden and internationally. The company offers ConverLight, an electrochromic glass, which provides UV protection for use in single glass pane and insulating glass unit solutions. This glass is suitable for new construction, reconstruction, and renovation and offers ultraviolet protection that reduces the risk of fading interiors.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 1.14 | |||||
| Debt-to-EBITDA | -1.65 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -6.48 | |||||
| Beneish M-Score | -2.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -69.6 | |||||
| 3-Year EBITDA Growth Rate | 62.2 | |||||
| 3-Year EPS without NRI Growth Rate | 60.5 | |||||
| 3-Year FCF Growth Rate | 67.6 | |||||
| 3-Year Book Growth Rate | -51.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 91.07 | |||||
| 9-Day RSI | 85.16 | |||||
| 14-Day RSI | 79.15 | |||||
| 6-1 Month Momentum % | 41.83 | |||||
| 12-1 Month Momentum % | 5.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.54 | |||||
| Quick Ratio | 1.13 | |||||
| Cash Ratio | 0.69 | |||||
| Days Inventory | 701.83 | |||||
| Days Sales Outstanding | 114.76 | |||||
| Days Payable | 441.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -142.5 | |||||
| Shareholder Yield % | -80.93 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.14 | |||||
| Operating Margin % | -317.49 | |||||
| Net Margin % | -330.62 | |||||
| FCF Margin % | -367.66 | |||||
| ROE % | -80.15 | |||||
| ROA % | -31.55 | |||||
| ROIC % | -34.8 | |||||
| ROC (Joel Greenblatt) % | -43.39 | |||||
| ROCE % | -34.62 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.25 | |||||
| PB Ratio | 0.68 | |||||
| Price-to-Tangible-Book | 0.85 | |||||
| EV-to-EBIT | -2.54 | |||||
| EV-to-EBITDA | -2.74 | |||||
| EV-to-Revenue | 7.69 | |||||
| EV-to-FCF | -2.76 | |||||
| Earnings Yield (Greenblatt) % | -39.37 | |||||
| FCF Yield % | -62.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ChromoGenics AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.708 | ||
| EPS (TTM) (€) | -1.343 | ||
| Beta | 3.83 | ||
| Volatility % | 298.76 | ||
| 14-Day RSI | 79.15 | ||
| 14-Day ATR (€) | 0.036575 | ||
| 20-Day SMA (€) | 0.54815 | ||
| 12-1 Month Momentum % | 5.36 | ||
| 52-Week Range (€) | 0.08 - 1.11 | ||
| Shares Outstanding (Mil) | 6.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ChromoGenics AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ChromoGenics AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
ChromoGenics AB Frequently Asked Questions
What is ChromoGenics AB(FRA:384)'s stock price today?
The current price of FRA:384 is €0.82. The 52 week high of FRA:384 is €1.11 and 52 week low is €0.08.
When is next earnings date of ChromoGenics AB(FRA:384)?
The next earnings date of ChromoGenics AB(FRA:384) is 2024-08-23.
Does ChromoGenics AB(FRA:384) pay dividends? If so, how much?
ChromoGenics AB(FRA:384) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers